HK1220899A1 - 鑑於移植用於造血先祖細胞動員的 -苯甲酰基- - Google Patents
鑑於移植用於造血先祖細胞動員的 -苯甲酰基-Info
- Publication number
- HK1220899A1 HK1220899A1 HK16108975.4A HK16108975A HK1220899A1 HK 1220899 A1 HK1220899 A1 HK 1220899A1 HK 16108975 A HK16108975 A HK 16108975A HK 1220899 A1 HK1220899 A1 HK 1220899A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- mobilisation
- transplantation
- benzoyl
- view
- progenitor cells
- Prior art date
Links
- 108010060188 4-fluorobenzoyl-TN-14003 Proteins 0.000 title 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 title 1
- JJVZSYKFCOBILL-MKMRYRNGSA-N motixafortide Chemical compound NCCCC[C@@H]1NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccc(F)cc1 JJVZSYKFCOBILL-MKMRYRNGSA-N 0.000 title 1
- 238000002054 transplantation Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87614506P | 2006-12-21 | 2006-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1220899A1 true HK1220899A1 (zh) | 2017-05-19 |
Family
ID=39536828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16108975.4A HK1220899A1 (zh) | 2006-12-21 | 2016-07-27 | 鑑於移植用於造血先祖細胞動員的 -苯甲酰基- |
Country Status (7)
Country | Link |
---|---|
US (5) | US8455450B2 (zh) |
EP (5) | EP3011961B1 (zh) |
CA (2) | CA2673719C (zh) |
ES (1) | ES2842210T3 (zh) |
HK (1) | HK1220899A1 (zh) |
IL (1) | IL199468A (zh) |
WO (3) | WO2008075371A2 (zh) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8435939B2 (en) | 2000-09-05 | 2013-05-07 | Biokine Therapeutics Ltd. | Polypeptide anti-HIV agent containing the same |
EP1541585B1 (en) | 2002-08-27 | 2013-01-30 | Biokine Therapeutics Ltd. | Cxcr4 antagonist and use thereof |
EP3011961B1 (en) | 2006-12-21 | 2020-11-11 | Biokine Therapeutics LTD. | 4f-benzoyl-tn14003 for the mobilisation of hematopoietic progenitor cells in view of transplantation |
EP2396023A2 (en) | 2009-02-11 | 2011-12-21 | Yeda Research and Development Co. Ltd. | Short beta-defensin-derived peptides |
JP5715622B2 (ja) * | 2009-06-14 | 2015-05-07 | バイオカイン セラピューティックス リミテッド | 血小板レベルを増大させるためのペプチド療法 |
WO2012058241A2 (en) | 2010-10-26 | 2012-05-03 | University Of South Alabama | Methods and compositions for ameliorating pancreatic cancer |
WO2012095849A1 (en) | 2011-01-10 | 2012-07-19 | Biokine Therapeutics Ltd. | Peptides and compositions for the treatment of neuroectodermal derived tumors and retinoblastoma |
US20140206629A1 (en) * | 2011-02-17 | 2014-07-24 | Rhode Island Hospital | Stromal Derived Factor Inhibition And CXCR4 Blockade |
EP2684572B1 (en) | 2011-03-11 | 2019-05-22 | KM Biologics Co., Ltd. | Adjuvant composition containing citrulline |
US9682078B2 (en) | 2011-03-18 | 2017-06-20 | University Of Virginia Patent Foundation | Compositions and methods for tissue engineering and cell based therapies |
EP2841084B1 (en) | 2012-04-24 | 2018-05-30 | Biokine Therapeutics Ltd. | Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer |
WO2014021682A1 (ko) * | 2012-08-03 | 2014-02-06 | 가톨릭대학교 산학협력단 | CD11b+ CX3CR1+ 세포, 이의 이용 및 이의 대량 수집 방법 |
KR101419480B1 (ko) * | 2012-08-03 | 2014-07-14 | 가톨릭대학교 산학협력단 | CD11b+CX3CR1+ 세포의 대량 수집 방법 |
WO2016185475A1 (en) * | 2015-05-20 | 2016-11-24 | Biokine Therapeutics Ltd. | Methods of mesenchymal stem cell mobilization and expansion |
JP2018521983A (ja) | 2015-07-16 | 2018-08-09 | バイオカイン セラピューティックス リミテッド | がんを治療するための組成物および方法 |
US20180221393A1 (en) | 2015-08-03 | 2018-08-09 | Biokine Therapeutics Ltd. | Cxcr4 binding agents for treatment of diseases |
EP3368904A1 (en) * | 2015-10-30 | 2018-09-05 | Oxford University Innovation Ltd. | Peptide and biomarker associated with inflammatory disorders, and uses thereof |
BR112018016924A2 (pt) | 2016-02-23 | 2019-01-02 | Biokine Therapeutics Ltd | método de seleção de regime de tratamento para indivíduo que tem leucemia mieloide aguda (lma), método de maximização de resposta ao tratamento de leucemia mieloide aguda (lma), método de tratamento de lma, antagonista de cxcr4 e agente quimioterápico no tratamento de lma |
EP3709917A4 (en) | 2017-11-17 | 2021-07-28 | CryoConcepts LP | PORTABLE ELECTROMECHANICAL CRYOSURGICAL DEVICE |
AU2019375096B2 (en) * | 2018-11-09 | 2024-03-14 | Neopep Pharma Gmbh & Co. Kg | Polypeptides for the treatment of stress, immunoreaction and stroke syndromes |
EP4043041A1 (en) | 2021-02-15 | 2022-08-17 | Technische Universität München | Cxcr4-ligands for diagnostic and therapeutic use and precursors thereof |
Family Cites Families (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US5206018A (en) * | 1978-11-03 | 1993-04-27 | Ayerst, Mckenna & Harrison, Inc. | Use of rapamycin in treatment of tumors |
US4342828A (en) * | 1979-07-20 | 1982-08-03 | Morinaga Milk Industry Co., Ltd. | Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells |
JPS61227526A (ja) | 1984-07-25 | 1986-10-09 | Chugai Pharmaceut Co Ltd | 新規なコロニー刺激因子 |
EP0215126B1 (en) | 1985-02-08 | 1991-07-31 | Chugai Seiyaku Kabushiki Kaisha | Human granulocyte colony stimulating factor |
EP0396158A1 (en) | 1985-08-23 | 1990-11-07 | Kirin-Amgen, Inc. | Production of pluripotent granulocyte colony-stimulating factor |
US4810643A (en) | 1985-08-23 | 1989-03-07 | Kirin- Amgen Inc. | Production of pluripotent granulocyte colony-stimulating factor |
EP0220520B1 (en) | 1985-09-30 | 1991-09-18 | Chugai Seiyaku Kabushiki Kaisha | Human granulocyte colony stimulating factor |
JPH0618778B2 (ja) | 1985-10-04 | 1994-03-16 | 中外製薬株式会社 | 白血球減少症治療剤 |
EP0230980B2 (en) | 1986-01-22 | 1996-03-20 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical agent for promoting the recovery of hemopoietic capacity |
ES2036530T3 (es) | 1986-01-22 | 1993-06-01 | Chugai Seiyaku Kabushiki Kaisha | Utilizacion de un factor estimulante de las colonias granulociticas humano para preparar una composicion farmaceutica para el tratamiento de la leucemia mielogena. |
DK203187A (da) | 1986-04-22 | 1987-10-23 | Immunex Corp | Human g-csf proteinekspression |
GR871067B (en) | 1986-07-18 | 1987-11-19 | Chugai Pharmaceutical Co Ltd | Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor |
JPH0725689B2 (ja) | 1986-10-07 | 1995-03-22 | 中外製薬株式会社 | 顆粒球コロニ−刺激因子を含有する徐放性製剤 |
JP2618618B2 (ja) | 1988-03-04 | 1997-06-11 | 協和醗酵工業株式会社 | 抗g−csf誘導体、nd28モノクローナル抗体 |
NO176799C (no) | 1986-12-23 | 1995-05-31 | Kyowa Hakko Kogyo Kk | DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid |
CA1340810C (en) | 1988-03-31 | 1999-11-02 | Motoo Yamasaki | Polypeptide derivatives of human granulocyte colony stimulating factor |
ATE111921T1 (de) | 1988-06-03 | 1994-10-15 | Chugai Pharmaceutical Co Ltd | Menschlicher kristallinischer granulocyt- koloniestimulierungsfaktor und dessen herstellung. |
CA1339071C (en) | 1988-08-24 | 1997-07-29 | Koichiro Tsuji | Thrombus control agent |
US5218092A (en) | 1988-09-29 | 1993-06-08 | Kyowa Hakko Kogyo Co., Ltd. | Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains |
US5104651A (en) | 1988-12-16 | 1992-04-14 | Amgen Inc. | Stabilized hydrophobic protein formulations of g-csf |
EP0401384B1 (en) | 1988-12-22 | 1996-03-13 | Kirin-Amgen, Inc. | Chemically modified granulocyte colony stimulating factor |
IL96477A0 (en) | 1989-12-01 | 1991-08-16 | Amgen Inc | Megakaryocyte production |
GB9107846D0 (en) | 1990-04-30 | 1991-05-29 | Ici Plc | Polypeptides |
JP3249147B2 (ja) | 1990-06-01 | 2002-01-21 | キリン−アムジエン・インコーポレーテツド | 生理活性蛋白含有経口製剤 |
EP0459516A1 (en) | 1990-06-01 | 1991-12-04 | Kirin-Amgen, Inc. | Oral dosage form of biologically active proteins |
IE912365A1 (en) | 1990-07-23 | 1992-01-29 | Zeneca Ltd | Continuous release pharmaceutical compositions |
US5250732A (en) * | 1991-07-18 | 1993-10-05 | Genentech, Inc. | Ketamine analogues for treatment of thrombocytopenia |
FR2686900B1 (fr) | 1992-01-31 | 1995-07-21 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides ayant une activite de stimulation des colonies de granulocytes, leur preparation et compositions pharmaceutiques les contenant. |
JPH08504837A (ja) | 1993-10-14 | 1996-05-28 | 生化学工業株式会社 | 新規ポリペプチドおよびこれから調製される抗hiv剤 |
US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
US5492126A (en) * | 1994-05-02 | 1996-02-20 | Focal Surgery | Probe for medical imaging and therapy using ultrasound |
AU8053598A (en) * | 1997-05-23 | 1998-12-11 | Transurgical, Inc. | Mri-guided therapeutic unit and methods |
US6569418B1 (en) | 1997-12-11 | 2003-05-27 | University Of Maryland Biotechnology Institute | Immuno-modulating effects of chemokines in DNA vaccination |
JP2002506830A (ja) | 1998-03-13 | 2002-03-05 | ザ ユニバーシティ オブ ブリティッシュ コロンビア | 治療的ケモカイン受容体アンタゴニスト |
CA2305787A1 (en) * | 2000-05-09 | 2001-11-09 | The University Of British Columbia | Cxcr4 antagonist treatment of hematopoietic cells |
CA2245224A1 (en) | 1998-08-14 | 2000-02-14 | Jiang-Hong Giong | Chemokine receptor antagonists and chemotherapeutics |
WO2000009152A1 (en) | 1998-08-14 | 2000-02-24 | The University Of British Columbia | Therapeutic chemokine receptor antagonists |
US6178522B1 (en) * | 1998-06-02 | 2001-01-23 | Alliedsignal Inc. | Method and apparatus for managing redundant computer-based systems for fault tolerant computing |
AU5241099A (en) | 1998-07-31 | 2000-02-21 | Trustees Of Columbia University In The City Of New York, The | Use of inhibitors of the activation of cxcr4 receptor by sdf-1 in treating rheumatoid arthritis |
ES2222728T3 (es) * | 1998-10-05 | 2005-02-01 | Pharmexa A/S | Procedimiento de vacunacion terapeutica. |
WO2000024468A1 (de) * | 1998-10-27 | 2000-05-04 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren und vorrichtung zur regelung einer gezielten wärmedeponierung in ein material |
US20060079492A1 (en) * | 1999-10-25 | 2006-04-13 | Ahlem Clarence N | Compositions and treatment methods |
US6365583B1 (en) | 1999-02-02 | 2002-04-02 | Anormed, Inc. | Methods to enhance white blood cell count |
GB9902399D0 (en) * | 1999-02-03 | 1999-03-24 | Smithkline Beecham Plc | Compounds |
CZ20013483A3 (cs) * | 1999-03-29 | 2002-04-17 | Shire Biochem Inc. | Pouľití sloučenin podle vynálezu pro přípravu farmaceutických přípravků k léčení leukémie |
MXPA02005199A (es) | 1999-11-24 | 2002-11-07 | Schering Corp | Metodos para inhibir metastasis. |
AU2001236065A1 (en) | 2000-03-03 | 2001-09-12 | Nobutaka Fujii | Antiviral compounds |
WO2001085196A2 (en) | 2000-05-09 | 2001-11-15 | The University Of British Columbia | Cxcr4 antagonist treatment of hematopoietic cells |
CA2421183C (en) * | 2000-09-05 | 2015-06-16 | Seikagaku Corporation | Novel polypeptide and anti-hiv agent containing the same |
US8435939B2 (en) * | 2000-09-05 | 2013-05-07 | Biokine Therapeutics Ltd. | Polypeptide anti-HIV agent containing the same |
US20020159996A1 (en) * | 2001-01-31 | 2002-10-31 | Kandasamy Hariharan | Use of CD23 antagonists for the treatment of neoplastic disorders |
US7630750B2 (en) * | 2001-02-05 | 2009-12-08 | The Research Foundation For The State University Of New York | Computer aided treatment planning |
JP3374917B2 (ja) | 2001-02-16 | 2003-02-10 | サンケン電気株式会社 | スイッチング電源装置 |
US7169750B2 (en) * | 2001-07-31 | 2007-01-30 | Anormed, Inc. | Methods to mobilize progenitor/stem cells |
US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
EP1541585B1 (en) * | 2002-08-27 | 2013-01-30 | Biokine Therapeutics Ltd. | Cxcr4 antagonist and use thereof |
DE10240064A1 (de) | 2002-08-30 | 2004-03-11 | Universitätsklinikum Freiburg | CXCR4-Rezeptor-Antagonisten |
US7759336B2 (en) * | 2002-12-10 | 2010-07-20 | Ono Pharmaceutical Co., Ltd. | Nitrogen-containing heterocyclic compounds and medicinal use thereof |
US20050002939A1 (en) | 2002-12-23 | 2005-01-06 | Albert Zlotnik | Tumor killing/tumor regression using CXCR4 antagonists |
EP1608318A4 (en) | 2003-03-27 | 2009-07-29 | Univ Emory | CXCR4 ANTAGONISTS AND METHODS OF USE |
EP1613613B1 (en) | 2003-04-11 | 2021-06-02 | Genzyme Corporation | Cxcr4 chemokine receptor binding compounds |
US8012136B2 (en) * | 2003-05-20 | 2011-09-06 | Optimyst Systems, Inc. | Ophthalmic fluid delivery device and method of operation |
US7419667B2 (en) * | 2004-03-19 | 2008-09-02 | Morinaga Milk Industry Co. Ltd. | Drug for cancer therapy |
US20060035829A1 (en) * | 2004-08-13 | 2006-02-16 | Anormed Inc. | Chemokine combinations to mobilize progenitor/stem cells |
EP1848541A4 (en) * | 2005-02-07 | 2013-01-16 | Pharmalight Inc | METHOD AND DEVICE FOR OPHTHALMIC DELIVERY OF PHARMACEUTICALLY ACTIVE INGREDIENTS |
WO2007022523A2 (en) * | 2005-08-19 | 2007-02-22 | Genzyme Corporation | Methods to enhance chemotherapy |
PL2535403T3 (pl) * | 2005-12-08 | 2019-10-31 | Univ Louisville Res Found Inc | Bardzo małe komórki macierzyste typu embrionalnego (VSEL) oraz sposoby ich izolowania i zastosowania |
EP2489728A1 (en) * | 2006-06-15 | 2012-08-22 | Neostem, Inc | Processing procedure for peripheral blood stem cells |
AU2007281090A1 (en) * | 2006-08-02 | 2008-02-07 | Genzyme Corporation | Combination therapy |
EP2058395A4 (en) * | 2006-08-04 | 2009-12-09 | Univ Kurume | PEPTIDE DERIVED FROM KIF CAPABLE OF BINDING TO A HLA-A24 MOLECULE |
EP3011961B1 (en) * | 2006-12-21 | 2020-11-11 | Biokine Therapeutics LTD. | 4f-benzoyl-tn14003 for the mobilisation of hematopoietic progenitor cells in view of transplantation |
JP5715622B2 (ja) | 2009-06-14 | 2015-05-07 | バイオカイン セラピューティックス リミテッド | 血小板レベルを増大させるためのペプチド療法 |
US8685398B2 (en) | 2009-06-15 | 2014-04-01 | Biokine Therapeutics Ltd. | Chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer |
WO2012095849A1 (en) | 2011-01-10 | 2012-07-19 | Biokine Therapeutics Ltd. | Peptides and compositions for the treatment of neuroectodermal derived tumors and retinoblastoma |
EP2841084B1 (en) | 2012-04-24 | 2018-05-30 | Biokine Therapeutics Ltd. | Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer |
-
2007
- 2007-12-23 EP EP15169576.4A patent/EP3011961B1/en active Active
- 2007-12-23 WO PCT/IL2007/001598 patent/WO2008075371A2/en active Application Filing
- 2007-12-23 ES ES15169576T patent/ES2842210T3/es active Active
- 2007-12-23 WO PCT/IL2007/001596 patent/WO2008075369A2/en active Application Filing
- 2007-12-23 WO PCT/IL2007/001597 patent/WO2008075370A2/en active Application Filing
- 2007-12-23 CA CA2673719A patent/CA2673719C/en active Active
- 2007-12-23 EP EP15166376.2A patent/EP2942059A1/en not_active Withdrawn
- 2007-12-23 US US12/520,699 patent/US8455450B2/en active Active
- 2007-12-23 US US12/520,811 patent/US8663651B2/en active Active
- 2007-12-23 CA CA002673484A patent/CA2673484A1/en not_active Abandoned
- 2007-12-23 EP EP07849622A patent/EP2094274A4/en not_active Withdrawn
- 2007-12-23 EP EP07849623A patent/EP2104507A4/en not_active Withdrawn
- 2007-12-23 EP EP14153703.5A patent/EP2759302A3/en not_active Withdrawn
- 2007-12-23 US US12/520,803 patent/US20100184694A1/en not_active Abandoned
-
2009
- 2009-06-21 IL IL199468A patent/IL199468A/en active IP Right Grant
-
2012
- 2012-01-29 US US13/360,751 patent/US8765683B2/en active Active
-
2013
- 2013-05-08 US US13/889,442 patent/US20140030211A1/en not_active Abandoned
-
2016
- 2016-07-27 HK HK16108975.4A patent/HK1220899A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20100184694A1 (en) | 2010-07-22 |
EP2104507A4 (en) | 2011-05-25 |
WO2008075371A2 (en) | 2008-06-26 |
EP3011961B1 (en) | 2020-11-11 |
WO2008075370A3 (en) | 2016-06-09 |
US20100143334A1 (en) | 2010-06-10 |
WO2008075371A3 (en) | 2009-04-16 |
US20120207748A1 (en) | 2012-08-16 |
US8765683B2 (en) | 2014-07-01 |
WO2008075369A2 (en) | 2008-06-26 |
ES2842210T3 (es) | 2021-07-13 |
US20100166715A1 (en) | 2010-07-01 |
EP3011961A1 (en) | 2016-04-27 |
WO2008075369A3 (en) | 2009-04-09 |
CA2673484A1 (en) | 2008-06-26 |
EP2942059A1 (en) | 2015-11-11 |
EP2759302A2 (en) | 2014-07-30 |
EP2094274A2 (en) | 2009-09-02 |
WO2008075370A2 (en) | 2008-06-26 |
IL199468A (en) | 2017-06-29 |
EP2759302A3 (en) | 2014-11-05 |
EP2094274A4 (en) | 2011-05-11 |
CA2673719C (en) | 2018-07-24 |
CA2673719A1 (en) | 2008-06-26 |
US20140030211A1 (en) | 2014-01-30 |
EP2104507A2 (en) | 2009-09-30 |
US8455450B2 (en) | 2013-06-04 |
US8663651B2 (en) | 2014-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1220899A1 (zh) | 鑑於移植用於造血先祖細胞動員的 -苯甲酰基- | |
IL261851B (en) | Reprogramming of t cells and hematopoietic cells | |
ZA201804932B (en) | Materials and methods to enhance hematopoietic stem cells engraftment procedures | |
IL198892A0 (en) | Endodermal progenitor cells | |
IL192730A0 (en) | Codon optimized il-15 and il-15r-alpha genes for expression in mammalian cells | |
SG10201510384UA (en) | Cell culture improvements | |
PL2046946T3 (pl) | Hodowla pluripotencjalnych komórek macierzystych | |
EP2104492A4 (en) | OXYGEN FEED FOR A CELL TRANSPLANT AND VASCULARIZATION | |
GB0605878D0 (en) | Fuel cells | |
GB0614338D0 (en) | Fuel cells | |
GB2455472B (en) | Structure enclosing hematopoietic progenitor cells from ES cells and method for preparing blood cells using the same | |
GB0608079D0 (en) | Fuel cells | |
GB0622394D0 (en) | Differentiation of pluripotent cells | |
GB0614337D0 (en) | Fuel Cells | |
GB0623635D0 (en) | Pluripotent cell growth media | |
HK1134835A1 (zh) | 增加和轉移造血幹細胞的方法 | |
IL194894A0 (en) | Substrate for the growth of cultured cells in three dimensions | |
EP2146728A4 (en) | PRELIMINARY CELLS FROM THE HARN AND METHOD FOR THEIR USE | |
ZA200807462B (en) | Rehydration of fuel cells | |
EP2039422A4 (en) | OXYGEN STORAGE MATERIAL | |
GB0603815D0 (en) | Improvements in and relating to gas storage | |
EP2131868A4 (en) | PROGENITOR CELLS WITH CARDIAC SPECIFICITY | |
EP1907533A4 (en) | PRE-CELL CELLS AND USES THEREOF | |
GB0606671D0 (en) | Cell Culture | |
EP2454362A4 (en) | HEMATOPOIETIC STROMAL PROGENITOR CELLS AND USES THEREOF |